Cargando…

Bone Marrow Mast Cell Antibody-Targetable Cell Surface Protein Expression Profiles in Systemic Mastocytosis

Despite recent therapeutic advances, systemic mastocytosis (SM) remains an incurable disease due to limited complete remission (CR) rates even after novel therapies. To date, no study has evaluated the expression on SM bone marrow mast cells (BMMC) of large panel of cell surface suitable for antibod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dasilva-Freire, Noelia, Mayado, Andrea, Teodosio, Cristina, Jara-Acevedo, María, Álvarez-Twose, Iván, Matito, Almudena, Sánchez-Muñoz, Laura, Caldas, Carolina, Henriques, Ana, Muñoz-González, Javier I., García-Montero, Andrés C., Sánchez-Gallego, J. Ignacio, Escribano, Luis, Orfao, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387409/ https://www.ncbi.nlm.nih.gov/pubmed/30696068 http://dx.doi.org/10.3390/ijms20030552

Ejemplares similares

Imatinib in systemic mastocytosis: a phase IV clinical trial in patients lacking exon 17 KIT mutations and review of the literature
por: Alvarez-Twose, Iván, et al.
Publicado: (2016)

Mastocytosis presenting with mast cell‐mediator release‐associated symptoms elicited by cyclo oxygenase inhibitors: prevalence, clinical, and laboratory features
por: Rama, Tiago Azenha, et al.
Publicado: (2022)

Altered innate immune profile in blood of systemic mastocytosis patients
por: Pérez‐Pons, Alba, et al.
Publicado: (2022)

Serum Tryptase Monitoring in Indolent Systemic Mastocytosis: Association with Disease Features and Patient Outcome
por: Matito, Almudena, et al.
Publicado: (2013)

Advances in the understanding and clinical management of mastocytosis and clonal mast cell activation syndromes
por: González-de-Olano, David, et al.
Publicado: (2016)

COVID-19 infection in patients with mast cell disorders including mastocytosis does not impact mast cell activation symptoms
por: Giannetti, Matthew P., et al.
Publicado: (2021)

Comprehensive Analysis of Acquired Genetic Variants and Their Prognostic Impact in Systemic Mastocytosis
por: González-López, Oscar, et al.
Publicado: (2022)

Ex vivo identification and characterization of a population of CD13(high) CD105(+) CD45(−) mesenchymal stem cells in human bone marrow
por: Muñiz, Carmen, et al.
Publicado: (2015)

COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)
por: Bonadonna, Patrizia, et al.
Publicado: (2021)

Role of Mast Cells in the Pathogenesis of Pruritus in Mastocytosis
por: KWIATKOWSKA, Dominika, et al.
Publicado: (2021)

Mastocytosis patients' cognitive dysfunctions correlate with the presence of spindle‐shaped mast cells in bone marrow
por: Spolak‐Bobryk, Natalia, et al.
Publicado: (2022)

Protease profile of normal and neoplastic mast cells in the human bone marrow with special emphasis on systemic mastocytosis
por: Atiakshin, Dmitri, et al.
Publicado: (2021)

Mastocytosis and Mast Cell Activation Disorders: Clearing the Air
por: Jackson, Clayton Webster, et al.
Publicado: (2021)

Systemic Mastocytosis: Following the Tyrosine Kinase Inhibition Roadmap
por: Piris-Villaespesa, Miguel, et al.
Publicado: (2020)

Clearance of bone marrow mast cells after hypomethylating agent and venetoclax for systemic mastocytosis associated with myeloid neoplasia
por: Pourhassan, Hoda, et al.
Publicado: (2022)

Presumed mast cell choroidal infiltrate in aggressive systemic mastocytosis
por: Tran, Tu M., et al.
Publicado: (2020)

Epigenetic Changes in Neoplastic Mast Cells and Potential Impact in Mastocytosis
por: Reszka, Edyta, et al.
Publicado: (2021)

A Puzzling Mast Cell Trilogy: Anaphylaxis, MCAS, and Mastocytosis
por: Gülen, Theo
Publicado: (2023)

MARS: Mutation-Adjusted Risk Score for Advanced Systemic Mastocytosis
por: Jawhar, Mohamad, et al.
Publicado: (2019)

Immunophenotypic Characterization of Human Bone Marrow Mast Cells. A Flow Cytometric Study of Normal and Pathological Bone Marrow Samples
por: Escribano, Luis, et al.
Publicado: (1998)

Systemic mastocytosis presenting as cardiac tamponade with CD25(+) pericardial mast cells
por: Sukrithan, Vineeth K., et al.
Publicado: (2016)

Mast cells derived from systemic mastocytosis exhibit an increased responsiveness to hyperosmolarity
por: Lyberg, Katarina, et al.
Publicado: (2022)

Bone Marrow Mastocytosis: A Diagnostic Challenge
por: Zanotti, Roberta, et al.
Publicado: (2021)

Acute Myeloid Leukemia with Occult Systemic Mastocytosis or Atypical Mast Cells Post-induction
por: Khan, Salahuddin, et al.
Publicado: (2018)

Safety of COVID-19 vaccination in patients with mastocytosis and monoclonal mast cell activation syndrome
por: Kaakati, Rayan, et al.
Publicado: (2021)

Systemic Mastocytosis and Other Entities Involving Mast Cells: A Practical Review and Update
por: El Hussein, Siba, et al.
Publicado: (2022)

Insights in Anaphylaxis and Clonal Mast Cell Disorders
por: González-de-Olano, David, et al.
Publicado: (2017)

Intertriginous maculopapular mastocytosis in a patient with acute myeloid leukemia
por: Herrero-Moyano, María, et al.
Publicado: (2017)

P996: UTILITY OF KIT P.D816 IN MYELOID NEOPLASM WITHOUT DOCUMENTED SYSTEMIC MASTOCYTOSIS TO DETECT HIDDEN MAST CELLS IN BONE MARROW
por: Kim, D. H., et al.
Publicado: (2022)

STAT3 and STAT5B Mutations in T/NK-Cell Chronic Lymphoproliferative Disorders of Large Granular Lymphocytes (LGL): Association with Disease Features
por: Muñoz-García, Noemí, et al.
Publicado: (2020)

Circulating promastocytes and atypical mast cells in systemic mastocytosis associated with acute myelogenous leukaemia transformation
por: Altohami, Mohammed O. A., et al.
Publicado: (2021)

The Proliferation Index of Specific Bone Marrow Cell Compartments from Myelodysplastic Syndromes Is Associated with the Diagnostic and Patient Outcome
por: Matarraz, Sergio, et al.
Publicado: (2012)

KIT D816V Positive Acute Mast Cell Leukemia Associated with Normal Karyotype Acute Myeloid Leukemia
por: Lopes, Marta, et al.
Publicado: (2018)

Detection of circulating tumor cells in blood of pancreatic ductal adenocarcinoma patients
por: Mayado, Andrea, et al.
Publicado: (2020)

Systemic mastocytosis with KIT V560G mutation presenting as recurrent episodes of vascular collapse: response to disodium cromoglycate and disease outcome
por: Conde-Fernandes, Iolanda, et al.
Publicado: (2017)

Hodgkin’s lymphoma is a rare form of clonal haematological non-mast cell disease in systemic mastocytosis
por: Gasljevic, Gorana, et al.
Publicado: (2015)

Evolution of myelodisplasic syndrome with ring sideroblasts (MDS-RS) to systemic mastocytosis and aleukemic mast cell leukemia
por: Costa, Larissa da, et al.
Publicado: (2020)

Health-related quality of life and health literacy in patients with systemic mastocytosis and mast cell activation syndrome
por: Schmidt, Tobias Jürgen, et al.
Publicado: (2022)

Indolent systemic mastocytosis and aleukemic mast cell leukemia: Subtle diagnostic differences with distinct management approaches
por: Paiva, Marcelo L., et al.
Publicado: (2023)

Fatal Hymenoptera Venom–Triggered Anaphylaxis in Patients with Unrecognized Clonal Mast Cell Disorder—Is Mastocytosis to Blame?
por: Rijavec, Matija, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g12o7cn73k1bbm35svnhu0vgo9